repaglinide, a new oral hypoglycemic for type 2 diabetes
July 1999
Novo Nordisk is now marketing repaglinide, a new oral hypoglycemic for type 2 diabetes.
It's called GlucoNorm in Canada...and Prandin in the U.S.
This new drug is approved for use by itself...or in combination with metformin (Glucophage).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive